These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 13867397)

  • 1. An international collaborative study of the assay of the potency of poliomyelitis sera.
    BENTZON MW; EVANS DG; MAALOE O; PERKINS FT; SPAUN J
    Bull World Health Organ; 1962; 26(3):341-55. PubMed ID: 13867397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Collaborative study for the establishment of the Ph. Eur. BRP for oral poliomyelitis vaccine (OPV) Batch 3 for use in the potency assay.
    Buchheit KH; Daas A; Stalder J
    Pharmeuropa Spec Issue Biol; 2002 Jun; 2002(1):67-91. PubMed ID: 12448032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calibration of the Ph. Eur. Biological Reference Preparation (BRP) for tetanus vaccine (adsorbed) batch 3.
    Tierney R; Hockley J; Rigsby P; Terao E; Daas A; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2011 Jun; 2011(1):1-26. PubMed ID: 21619853
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The international standard for anti-Brucella-abortus serum.
    STABLEFORTH AW
    Bull World Health Organ; 1954; 10(6):927-35. PubMed ID: 13199656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. INTERNATIONAL STANDARDS FOR ANTI-POLIOVIRUS SERA TYPES 1, 2 AND 3.
    LYNG J; BENTZON MW
    Bull World Health Organ; 1963; 29(6):711-20. PubMed ID: 14107743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. International collaborative assay of the international reference preparation of anti-yellow-fever serum.
    Krag P; Macnamara FN; Lyng J; Bentzon MW; Larsen SO
    Bull World Health Organ; 1965; 33(2):243-55. PubMed ID: 5294595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An international collaborative study of an anti-infectious bursal disease virus reference serum.
    Reed NE; Thornton DH; Hebert CN; Muskett JC; Wood GW
    J Biol Stand; 1989 Oct; 17(4):361-9. PubMed ID: 2559083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neutralizing-antibody-combining (NAC) test for measuring antigenic potency of poliomyelitis vaccine.
    BENYESH-MELNICK M; MELNICK JL
    Bull World Health Organ; 1959; 20(6):1075-98. PubMed ID: 13799058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.
    Gaines-Das R; Horiuchi Y; Zhang SM; Newland P; Kim Y; Corbel M; Xing D
    Vaccine; 2009 Nov; 27(49):6824-32. PubMed ID: 19765397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Collaborative study for the validation of serological methods for potency testing of diphtheria toxoid vaccines-part 1.
    Winsnes R; Sesardic D; Daas A; Behr-Gross ME
    Pharmeuropa Bio; 2004 Jan; 2003(2):35-68. PubMed ID: 14960262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and standardization of antiserums prepared with the three known types to poliomyelitis viruses.
    WENNER HA; MILLER CA; KAMITSUKA P; WILSON JC
    Am J Hyg; 1954 Mar; 59(2):221-35. PubMed ID: 13138587
    [No Abstract]   [Full Text] [Related]  

  • 12. Preparation of a respiratory syncytial virus human reference serum for use in the quantitation of neutralization antibody.
    Yang DP; Zielinska E; Quiroz J; Madore D; Rappaport R
    Biologicals; 2007 Jun; 35(3):183-7. PubMed ID: 17241789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The international reference preparation of influenza virus haemagglutinin (type A).
    Krag P; Bentzon MW
    Bull World Health Organ; 1971; 45(4):473-86. PubMed ID: 5317082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta.
    Meager A; Das RG
    J Immunol Methods; 2005 Nov; 306(1-2):1-15. PubMed ID: 16226271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. European Pharmacopoeia biological reference preparation for poliomyelitis vaccine (inactivated): collaborative study for the establishment of batch No. 3.
    Martin J; Daas A; Milne C
    Pharmeur Bio Sci Notes; 2016; 2016():135-150. PubMed ID: 28279255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A comparative study of the methods of preparation of type-specific and polyvalent diagnostic poliomyelitis sera].
    GRAEVSKAIA NA; ROMANOVA LN; BELIAEV AL
    Vopr Virusol; 1961; 6():630-3. PubMed ID: 13900974
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishment of European Pharmacopoeia BRP batch 2 for inactivated poliomyelitis vaccine for in vitro D antigen assay.
    Fuchs F; Minor P; Daas A; Milne C
    Pharmeuropa Bio; 2003 Jul; 2003(1):23-50. PubMed ID: 14563307
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Second International Standard for anti-poliovirus sera types 1, 2 and 3.
    Wood DJ; Heath AB
    Biologicals; 1992 Sep; 20(3):203-11. PubMed ID: 1333776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calibration of European pharmacopoeia biological reference preparation for diphtheria vaccine (adsorbed) batch 4.
    Stickings P; Rigsby P; Buchheit KH; Sesardic D
    Pharmeur Bio Sci Notes; 2009 Oct; 2009(1):1-9. PubMed ID: 20144448
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International collaborative study for the establishment of the second International Reference Preparation of plasmin.
    Gaffney PJ; Mussett MV
    Thromb Haemost; 1983 Oct; 50(3):645-9. PubMed ID: 6228030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.